Theraclion SA (EPA:ALTHE)

Market Cap	48.25M +58.5%
Revenue (ttm)	480.00K -72.8%
Net Income	-6.76M
EPS	n/a
Shares Out	73.11M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	216,010
Open	0.6360
Previous Close	0.6400
Day's Range	0.6150 - 0.6700
52-Week Range	0.4020 - 0.9300
Beta	0.42
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 14, 2026

About Theraclion

Theraclion SA provides therapeutic ultrasound technology for seamless vein care. It offers SONOVEIN, a robotic solution for the non-invasive echotherapy treatment of varicose veins; ECHOPULSE, a robotic and non-invasive solution for the echotherapy treatment of thyroid nodules and breast fibroadenoma; and EPack, a disposable that is installed on the device before treatment to protect the patient’s skin and optimize image quality. The company was incorporated in 2004 and is headquartered in Malakoff, France.

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2004
• Employees: 40
• Stock Exchange: Euronext Paris
• Ticker Symbol: ALTHE

Financial Performance

In 2025, Theraclion's revenue was 652,000, a decrease of -21.35% compared to the previous year's 829,000. Losses were -5.69 million, -1.16% less than in 2024.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Nov 11, 2026

Data Sources Report a data error